Mink Brook Asset Management LLC Makes New $743,000 Investment in MDxHealth SA $MDXH

Mink Brook Asset Management LLC bought a new stake in shares of MDxHealth SA (NASDAQ:MDXH) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 159,734 shares of the company’s stock, valued at approximately $743,000. MDxHealth makes up about 0.5% of Mink Brook Asset Management LLC’s portfolio, making the stock its 26th biggest position. Mink Brook Asset Management LLC owned approximately 0.34% of MDxHealth at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. FreeGulliver LLC purchased a new stake in shares of MDxHealth during the 2nd quarter worth $273,000. Calamos Advisors LLC bought a new position in shares of MDxHealth during the 3rd quarter worth approximately $305,000. GSA Capital Partners LLP acquired a new stake in MDxHealth in the third quarter valued at approximately $48,000. Jefferies Financial Group Inc. purchased a new position in MDxHealth in the third quarter worth $53,000. Finally, Russell Investments Group Ltd. acquired a new position in shares of MDxHealth during the third quarter worth $461,000.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on MDXH shares. Weiss Ratings restated a “sell (d-)” rating on shares of MDxHealth in a research note on Monday, December 29th. BTIG Research reaffirmed a “buy” rating and issued a $7.00 price objective on shares of MDxHealth in a research report on Tuesday, December 23rd. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $7.75.

MDxHealth Stock Performance

MDxHealth stock opened at $3.37 on Tuesday. The business’s 50-day simple moving average is $3.52 and its two-hundred day simple moving average is $3.78. The company has a market cap of $166.82 million, a PE ratio of -5.03 and a beta of 1.61. MDxHealth SA has a fifty-two week low of $1.36 and a fifty-two week high of $5.33.

MDxHealth (NASDAQ:MDXH) last released its earnings results on Thursday, February 26th. The company reported $999.00 EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $999.13. MDxHealth had a negative return on equity of 1,078.01% and a negative net margin of 31.07%.The firm had revenue of $29.55 million during the quarter, compared to the consensus estimate of $26.05 million. As a group, analysts predict that MDxHealth SA will post -1.15 EPS for the current fiscal year.

MDxHealth Company Profile

MDxHealth, headquartered in Mechelen, Belgium, with a U.S. presence in Newton, Massachusetts, is a molecular diagnostics company focused on improving the accuracy of cancer diagnosis and treatment decision making through epigenetic biomarker assays. The company specializes in developing and commercializing tests that detect DNA methylation changes associated with urological cancers, enabling more precise risk stratification and patient management.

MDxHealth’s lead product portfolio includes ConfirmMDx and SelectMDx.